---
title: "Allmed: Net profit in the first quarter of 2025 was 86.5027 million yuan, a year-on-year decrease of 7.86%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237615256.md"
description: "Allmed announced that its revenue for the first quarter of 2025 was 759 million yuan, a year-on-year increase of 1.64%; net profit was 86.5027 million yuan, a year-on-year decrease of 7.86%"
datetime: "2025-04-25T18:28:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237615256.md)
  - [en](https://longbridge.com/en/news/237615256.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237615256.md)
---

# Allmed: Net profit in the first quarter of 2025 was 86.5027 million yuan, a year-on-year decrease of 7.86%

Allmed announced that its revenue for the first quarter of 2025 was 759 million yuan, a year-on-year increase of 1.64%; net profit was 86.5027 million yuan, a year-on-year decrease of 7.86%

### Related Stocks

- [002950.CN](https://longbridge.com/en/quote/002950.CN.md)

## Related News & Research

- [Comey eyes new 'anti-weaponization' fund: 'I'm guessing I'll be in line'](https://longbridge.com/en/news/286948735.md)
- [Trump faces record-low approval on inflation as retirees struggle](https://longbridge.com/en/news/286834439.md)
- [09:06 ETHarmony Comes to the Massachusetts State House as The Platters® Prepare Their Musical Love Letter to the World](https://longbridge.com/en/news/286918739.md)
- [13:41 ETUT Haslam Marks Decade in Major International Ranking's Top Five U.S. Public Schools](https://longbridge.com/en/news/286804132.md)
- [20:00 ETAccro Bioscience Announces $50 Million Series C Financing Led by OrbiMed to Advance Clinical Pipeline for Immune Mediated Diseases](https://longbridge.com/en/news/286830151.md)